ERBB3 and neoplasm: Whilst we did not see full IRE1α control over baseline HER3 levels, the response to osimertinib-induced stress was dependent on IRE1α, illustrating the complex evolutive mechanisms allowing tumor cells to rewire adaptive pathways in response to chemotherapy.